The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy
Open accessAbstract
Reactive oxygen species (ROS) and their products are components of cell signaling pathways and play important roles in cellular physiology and pathophysiology. Under physiological conditions, cells control ROS levels by the use of scavenging systems such as superoxide dismutases, peroxiredoxins, and glutathione that balance ROS generation and elimination. Under oxidative stress conditions, excessive ROS can damage cellular proteins, lipids, and DNA, leading to cell damage that may contribute to carcinogenesis. Several studies have shown that cancer cells display an adaptive response to oxidative stress by increasing expression of antioxidant enzymes and molecules. As a double‐edged sword, ROS influence signaling pathways determining beneficial or detrimental outcomes in cancer therapy. In this review, we address the role of redox homeostasis in cancer growth and therapy and examine the current literature regarding the redox regulatory systems that become upregulated in cancer and their role in promoting tumor progression and resistance to chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rosato, R. R., Kolla, S. S., Hock, S. K., Almenara, J. A., Patel, A. K., Amin, S., Atadja, P. W., Fisher, P. B., Dent, P., & Grant, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095208 · Cited by 65
RetractedMcCord, J. M., & Fridovich, I. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63504-5 · Cited by 12,952
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 1×
“It has been demonstrated that HIF-1α interacts with the HIF-1β and acts as a transcription factor able to induce the expression of genes involved in metabolic adaptation, such as hexokinase II (HK II) and pyruvate dehydrogenase kinase 1 (PDK1) [216], and the expression of genes involved in improving oxygen availabilit…”
BackgroundWang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Crosstalk of reactive oxygen species and NF-κB signaling
Morgan, M. J., & Liu, Z.-G. (2011) · Cell Research · doi:10.1038/cr.2010.178 · Cited by 3,505
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Robert, C., Karaszewska, B., Schachter, J., Rutkowski, P., Mackiewicz, A., Stroiakovski, D., Lichinitser, M., Dummer, R., Grange, F., Mortier, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412690 · Cited by 2,701
Nordberg, J., & Arnér, E. S. J. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00724-9 · Cited by 2,662
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
Richardson, P. G., Barlogie, B., Berenson, J., Singhal, S., Jagannath, S., Irwin, D., Rajkumar, S. V., Srkalovic, G., Alsina, M., Alexanian, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030288 · Cited by 2,632
Physiological functions of thioredoxin and thioredoxin reductase
Arnér, E. S. J., & Holmgren, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01701.x · Cited by 2,525
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1
Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., & Ichijo, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2596 · Cited by 2,377
WISEMAN, H., & HALLIWELL, B. (1996) · Biochemical Journal · doi:10.1042/bj3130017 · Cited by 2,345
Ichijo, H., Nishida, E., Irie, K., Dijke, P. T., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., & Gotoh, Y. (1997) · Science · doi:10.1126/science.275.5296.90 · Cited by 2,307
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase
Li, Y., Huang, T.-T., Carlson, E. J., Melov, S., Ursell, P. C., Olson, J. L., Noble, L. J., Yoshimura, M. P., Berger, C., Chan, P. H., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-376 · Cited by 1,789
Glutathione and its role in cellular functions
Sies, H. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00177-x · Cited by 1,735
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712 · cited 1×
“It has been demonstrated that HIF-1α interacts with the HIF-1β and acts as a transcription factor able to induce the expression of genes involved in metabolic adaptation, such as hexokinase II (HK II) and pyruvate dehydrogenase kinase 1 (PDK1) [216], and the expression of genes involved in improving oxygen availabilit…”
BackgroundThe p66shc adaptor protein controls oxidative stress response and life span in mammals
Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P. P., Lanfrancone, L., & Pelicci, P. G. (1999) · Nature · doi:10.1038/46311 · Cited by 1,712
Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications
Maines, M. D. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.10.3290025 · Cited by 1,707
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610 · cited 1×
“It is kept at low levels by several E3 ubiquitin ligases, such as Mdm2, responsible for its degradation [178], and it is stabilized by posttranslational modifications such as phosphorylation, acetylation, and methylation [179, 180].”
BackgroundHideshima, T., Richardson, P. G. G., Chauhan, D., Palombella, V. J., Elliott, P. J., Adams, J., & Anderson, K. C. (2001) · PubMed · Cited by 1,508
The emerging role of the Nrf2–Keap1 signaling pathway in cancer
Jaramillo, M. C., & Zhang, D. D. (2013) · Genes & Development · doi:10.1101/gad.225680.113 · Cited by 1,297
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
Keyse, S. M., & Tyrrell, R. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.99 · Cited by 1,264
Role of Glutathione in Cancer Progression and Chemoresistance
Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A. L., Pronzato, M. A., Marinari, U. M., & Domenicotti, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/972913 · Cited by 1,208
Self-citationBiologic and pharmacologic regulation of mammalian glutathione synthesis
Griffith, O. W. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00176-8 · Cited by 1,190
Ubiquitin signalling in the NF-κB pathway
Chen, Z. J. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-758 · Cited by 1,184
The antioxidant function of the p53 tumor suppressor
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,121
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
Singh, A., Misra, V., Thimmulappa, R. K., Lee, H., Ames, S., Hoque, M. O., Herman, J. G., Baylin, S. B., Sidransky, D., Gabrielson, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030420 · Cited by 1,060
Harris, I. S., Treloar, A. E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K. C., Yung, K. Y., Brenner, D., Knobbe-Thomsen, C. B., Cox, M. A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.019 · Cited by 993
Protein kinase C and other diacylglycerol effectors in cancer
Griner, E. M., & Kazanietz, M. G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2110 · Cited by 978
Vousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
Hu, W., Zhang, C., Wu, R., Sun, Y., Levine, A., & Feng, Z. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001006107 · Cited by 862
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
Ho, A. L., Grewal, R. K., Leboeuf, R., Sherman, E. J., Pfister, D. G., Deandreis, D., Pentlow, K. S., Zanzonico, P. B., Haque, S., Gavane, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209288 · Cited by 843
The role of hypoxia-inducible factors in tumorigenesis
Rankin, E. B., & Giaccia, A. J. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.21 · Cited by 806
Redox-based regulation of signal transduction: principles, pitfalls, and promises
Janssen-Heininger, Y. M. W., Mossman, B. T., Heintz, N. H., Forman, H. J., Kalyanaraman, B., Finkel, T., Stamler, J. S., Rhee, S. G., & van der Vliet, A. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.011 · Cited by 784
Oxidative stress and apoptosis: Impact on cancer therapy
Ozben, T. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20874 · Cited by 751
Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
Padmanabhan, B., Tong, K. I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M.-I., Kobayashi, A., Yokoyama, S., & Yamamoto, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.013 · Cited by 735
Shibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M., & Hirohashi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806268105 · Cited by 728
Drugging the p53 pathway: understanding the route to clinical efficacy
Khoo, K. H., Verma, C. S., & Lane, D. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4236 · Cited by 719
Griffith, O. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33504-x · Cited by 701
Pham, C. G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alvarez, K., Jayawardena, S., De Smaele, E., Cong, R., Beaumont, C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.10.017 · Cited by 663
Kim, J.-W., Gao, P., Liu, Y.-C., Semenza, G. L., & Dang, C. V. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00440-07 · Cited by 658
Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling
Perkins, A., Nelson, K. J., Parsonage, D., Poole, L. B., & Karplus, P. A. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.05.001 · Cited by 645
Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth
Ohta, T., Iijima, K., Miyamoto, M., Nakahara, I., Tanaka, H., Ohtsuji, M., Suzuki, T., Kobayashi, A., Yokota, J., Sakiyama, T., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5003 · Cited by 629
ROS, stress‐activated kinases and stress signaling in cancer
Benhar, M., Engelberg, D., & Levitzki, A. (2002) · The EMBO Reports · doi:10.1093/embo-reports/kvf094 · Cited by 600
When NRF2 Talks, Who's Listening?
Wakabayashi, N., Slocum, S. L., Skoko, J. J., Shin, S., & Kensler, T. W. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3216 · Cited by 595
PRIMA-1 reactivates mutant p53 by covalent binding to the core domain
Lambert, J. M. R., Gorzov, P., Veprintsev, D. B., Söderqvist, M., Segerbäck, D., Bergman, J., Fersht, A. R., Hainaut, P., Wiman, K. G., & Bykov, V. J. N. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.003 · Cited by 592
Harvey, C. J., Thimmulappa, R. K., Singh, A., Blake, D. J., Ling, G., Wakabayashi, N., Fujii, J., Myers, A., & Biswal, S. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.040 · Cited by 544
Yap, T. A., Yan, L., Patnaik, A., Fearen, I., Olmos, D., Papadopoulos, K., Baird, R. D., Delgado, L., Taylor, A., Lupinacci, L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5263 · Cited by 539
Kang, S. S., Kwon, T., Kwon, D. Y., & Do, S. I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13085 · Cited by 480
Movafagh, S., Crook, S., & Vo, K. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25074 · Cited by 469
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
Semenza, G. L. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.009 · Cited by 469
Mehta, M. P., Rodrigus, P., Terhaard, C. H. J., Rao, A., Suh, J., Roa, W., Souhami, L., Bezjak, A., Leibenhaut, M., Komaki, R., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.122 · Cited by 463
Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities
Wondrak, G. T. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2541 · Cited by 462
Non-Classical P38 Map Kinase Functions: Cell Cycle Checkpoints and Survival
Thornton, T. M., & Rincon, M. (2009) · International Journal of Biological Sciences · doi:10.7150/ijbs.5.44 · Cited by 443
ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair
Cosentino, C., Grieco, D., & Costanzo, V. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.330 · Cited by 435
Map kinase signaling pathways and hematologic malignancies
Platanias, L. C. (2003) · Blood · doi:10.1182/blood-2002-12-3647 · Cited by 432
Kallio, P. J., Pongratz, I., Gradin, K., McGuire, J., & Poellinger, L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5667 · Cited by 415
Ma, M. H., Yang, H. H., Parker, K., Manyak, S. J., Friedman, J. M., Altamirano, C. V., Wu, Z.-Q., Borad, M. J., Frantzen, M., Roussos, E., et al. (2003) · PubMed · Cited by 414
Farley, J., Brady, W. E., Vathipadiekal, V., Lankes, H. A., Coleman, R., Morgan, M. A., Mannel, R., Yamada, S. D., Mutch, D., Rodgers, W. H., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70572-7 · Cited by 413
Gopalakrishna, R., & Anderson, W. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6758 · Cited by 407
Genomic alterations in lung adenocarcinoma
Devarakonda, S., Morgensztern, D., & Govindan, R. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00077-7 · Cited by 404
Myant, K. B., Cammareri, P., McGhee, E. J., Ridgway, R. A., Huels, D. J., Cordero, J. B., Schwitalla, S., Kalna, G., Ogg, E.-L., Athineos, D., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.04.006 · Cited by 391
Signal Transduction by Mitochondrial Oxidants
Finkel, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.271999 · Cited by 390
p53-Induced Up-Regulation of MnSOD and GPx but not Catalase Increases Oxidative Stress and Apoptosis
Hussain, S. P., Amstad, P., He, P., Robles, A., Lupold, S., Kaneko, I., Ichimiya, M., Sengupta, S., Mechanic, L., Okamura, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2287-2 · Cited by 384
Heme Oxygenase-1 in Tumors: Is It a False Friend?
Jozkowicz, A., Was, H., & Dulak, J. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1659 · Cited by 382
Chang, L., Graham, P. H., Hao, J., Ni, J., Bucci, J., Cozzi, P. J., Kearsley, J. H., & Li, Y. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.407 · Cited by 377
p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway
Hui, L., Bakiri, L., Mairhorfer, A., Schweifer, N., Haslinger, C., Kenner, L., Komnenovic, V., Scheuch, H., Beug, H., & Wagner, E. F. (2007) · Nature Genetics · doi:10.1038/ng2033 · Cited by 352
Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity
Cao, J., Schulte, J., Knight, A., Leslie, N. R., Zagozdzon, A., Bronson, R., Manevich, Y., Beeson, C., & Neumann, C. A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.101 · Cited by 344
The thioredoxin-thioredoxin reductase system: over-expression in human cancer.
Lincoln, D. T., Emadi, E. M. A., Tonissen, K. F., & Clarke, F. M. (2003) · PubMed · Cited by 337
Shen, J., Person, M. D., Zhu, J., Abbruzzese, J. L., & Li, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-3262 · Cited by 337
Lipid peroxidation, free radical production and antioxidant status in breast cancer
Ray, G., Batra, S., Shukla, N. K., Deo, S., Raina, V., Ashok, S., & Husain, S. A. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006357330486 · Cited by 335
Disulfiram Facilitates Intracellular Cu Uptake and Induces Apoptosis in Human Melanoma Cells
Cen, D., Brayton, D., Shahandeh, B., Meyskens, & Farmer, P. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049568z · Cited by 334
Cancer-Associated Protein Kinase C Mutations Reveal Kinase’s Role as Tumor Suppressor
Antal, C. E., Hudson, A. M., Kang, E., Zanca, C., Wirth, C., Stephenson, N. L., Trotter, E. W., Gallegos, L. L., Miller, C. J., Furnari, F. B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.001 · Cited by 330
Reactive Oxygen Species in Cancer Stem Cells
Shi, X., Zhang, Y., Zheng, J., & Pan, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4529 · Cited by 325
Thioredoxin‐2 (TRX‐2) is an essential gene regulating mitochondria‐dependent apoptosis
Tanaka, T., Hosoi, F., Yamaguchi‐Iwai, Y., Nakamura, H., Masutani, H., Ueda, S., Nishiyama, A., Takeda, S., Wada, H., Spyrou, G., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1695 · Cited by 322
p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation
Ventura, J. J., Tenbaum, S., Perdiguero, E., Huth, M., Guerra, C., Barbacid, M., Pasparakis, M., & Nebreda, A. R. (2007) · Nature Genetics · doi:10.1038/ng2037 · Cited by 304
Redox-Sensitive Kinases of the Nuclear Factor-κB Signaling Pathway
Pantano, C., Reynaert, N. L., Vliet, A. V. D., & Janssen–Heininger, Y. M. W. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1791 · Cited by 303
Weber, C. K., Liptay, S., Wirth, T., Adler, G., & Schmid, R. M. (2000) · Gastroenterology · doi:10.1053/gast.2000.19458 · Cited by 299
The Nrf2/HO‐1 Axis in Cancer Cell Growth and Chemoresistance
Furfaro, A. L., Traverso, N., Domenicotti, C., Piras, S., Moretta, L., Marinari, U. M., Pronzato, M. A., & Nitti, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1958174 · Cited by 295
Self-citationPKC412--a protein kinase inhibitor with a broad therapeutic potential.
Fabbro, D., Ruetz, S., Bodis, S. B., Pruschy, M. N., Csermak, K., Man, A., Campochiaro, P. A., Wood, J. M., O'Reilly, T., & Meyer, T. (2000) · PubMed · Cited by 271
Nuclear initiated NF-κB signaling: nemo and ATM take center stage
Miyamoto, S. (2011) · Cell Research · doi:10.1038/cr.2010.179 · Cited by 253
A Comparison of Thiol Peroxidase Mechanisms
Flohé, L., Toppo, S., Cozza, G., & Ursini, F. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3397 · Cited by 249
Ravn-Haren, G., Olsen, A., Tjønneland, A., Dragsted, L. O., Nexø, B. A., Wallin, H., Overvad, K., Raaschou-Nielsen, O., & Vogel, U. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi267 · Cited by 248
Heme Oxygenase-1: Redox Regulation of a Stress Protein in Lung and Cell Culture Models
Ryter, S. W., & Choi, A. M. K. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.80 · Cited by 243
The emerging role of reactive oxygen species in cancer therapy
Renschler, M. F. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.02.031 · Cited by 237
Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma
Kinnula, V. L., Lehtonen, S., Sormunen, R., Kaarteenaho‐Wiik, R., Kang, S. W., Rhee, S. G., & Soini, Y. (2002) · The Journal of Pathology · doi:10.1002/path.1042 · Cited by 233
Regulation of reactive oxygen species, DNA damage and c-Myc function by peroxiredoxin 1
Egler, R. A., Fernandes, E., Rothermund, K., Sereika, S., de Souza-Pinto, N., Jaruga, P., Dizdaroglu, M., & Prochownik, E. V. (2005) · Oncogene · doi:10.1038/sj.onc.1208821 · Cited by 231
Perifosine: Update on a novel Akt inhibitor
Gills, J. J., & Dennis, P. A. (2009) · Current Oncology Reports · doi:10.1007/s11912-009-0016-4 · Cited by 221
Goldman, E. H., Chen, L., & Fu, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311129200 · Cited by 218
A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity
Nioi, P., & Nguyen, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.051 · Cited by 212
Sun, X., Wu, F., Datta, R., Kharbanda, S., & Kufe, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7470 · Cited by 208
Liu, L.-Z., Hu, X.-W., Xia, C., He, J., Zhou, Q., Shi, X., Fang, J., & Jiang, B.-H. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.08.003 · Cited by 205
Zhou, S., Kachhap, S., Sun, W., Wu, G., Chuang, A., Poeta, L., Grumbine, L., Mithani, S. K., Chatterjee, A., Koch, W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610818104 · Cited by 198
Molecular Basis of Heme Oxygenase-1 Induction: Implications for Chemoprevention and Chemoprotection
Prawan, A., Kundu, J. K., & Surh, Y.-J. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1688 · Cited by 195
The enigmatic protein kinase Cδ: complex roles in cell proliferation and survival
Jackson, D. N., & Foster, D. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0979rev · Cited by 195
Cellular Redox Pathways as a Therapeutic Target in the Treatment of Cancer
Montero, A. J., & Jassem, J. (2011) · Drugs · doi:10.2165/11592590-000000000-00000 · Cited by 194
Overexpression of Heme Oxygenase-1 in Murine Melanoma
Was, H., Cichon, T., Smolarczyk, R., Rudnicka, D., Stopa, M., Chevalier, C., Leger, J. J., Lackowska, B., Grochot, A., Bojkowska, K., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051365 · Cited by 192
Kim, M., Lee, E.-J., Kim, H.-R. C., & Moon, A. (2003) · PubMed · Cited by 190
Forman, H. J., Torres, M., & Fukuto, J. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1015913229650 · Cited by 189
Hu, R., Saw, C. L.-L., Yu, R., & Kong, A.-N. T. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3276 · Cited by 187
Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.
Soini, Y., Kahlos, K., Näpänkangas, U., Kaarteenaho–Wiik, R., Säily, M., Koistinen, P., Pääakkö, P., Holmgren, A., & Kinnula, V. L. (2001) · PubMed · Cited by 187
Xc− inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism
Ma, M.-Z., Chen, G., Wang, P., Lu, W.-H., Zhu, C.-F., Song, M., Yang, J., Wen, S., Xu, R.-H., Hu, Y., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.031 · Cited by 186
Riobo, N. A., Haines, G. M., & Emerson, C. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2539 · Cited by 181
Anti-HIV drugs for cancer therapeutics: back to the future?
Chow, W. A., Jiang, C., & Guan, M. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70334-6 · Cited by 181
Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis.
Gökmen‐Polar, Y., Murray, N. R., Velasco, M. A. D., Gatalica, Z., & Fields, A. P. (2001) · PubMed · Cited by 180
Peroxiredoxins, a novel protein family in lung cancer
Lehtonen, S. T., Svensk, A., Soini, Y., Pääkkö, P., Hirvikoski, P., Kang, S. W., Säily, M., & Kinnula, V. L. (2004) · International Journal of Cancer · doi:10.1002/ijc.20294 · Cited by 173
Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases
Park, M. H., Jo, M., Kim, Y. R., Lee, C.-K., & Hong, J. T. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.018 · Cited by 173
Oxidative Stress in Breast Cancer
Taş, F., Hansel, H., Belce, A., İlvan, Ş., Argon, A., Çamlıca, H., & Topuz, E. (2005) · Medical Oncology · doi:10.1385/mo:22:1:011 · Cited by 170
p53 is balancing development, differentiation and de-differentiation to assure cancer prevention
Molchadsky, A., Rivlin, N., Brosh, R., Rotter, V., & Sarig, R. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq101 · Cited by 168
Heme Oxygenase-1: A Metabolic Nike
Wegiel, B., Nemeth, Z., Correa-Costa, M., Bulmer, A. C., & Otterbein, L. E. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5667 · Cited by 166
The Redox Regulation of PI 3-Kinase–Dependent Signaling
Leslie, N. R. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1765 · Cited by 163
Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.
O'Dwyer, P. J., Hamilton, T. C., LaCreta, F. P., Gallo, J. M., Kilpatrick, D., Halbherr, T., Brennan, J., Bookman, M. A., Hoffman, J., Young, R. C., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.249 · Cited by 162
Motexafin gadolinium: A novel redox active drug for cancer therapy
Magda, D., & Miller, R. A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.09.002 · Cited by 162
The p53-induced Gene-6 (Proline Oxidase) Mediates Apoptosis through a Calcineurin-dependent Pathway
Rivera, A., & Maxwell, S. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504852200 · Cited by 160
Brunner, T. B., Geiger, M., Grabenbauer, G. G., Lang-Welzenbach, M., Mantoni, T. S., Cavallaro, A., Sauer, R., Hohenberger, W., & McKenna, W. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2355 · Cited by 159
Switching Akt: from survival signaling to deadly response
Los, M., Maddika, S., Erb, B., & Schulze‐Osthoff, K. (2009) · BioEssays · doi:10.1002/bies.200900005 · Cited by 158
Hill, M., Pereira, V., Chauveau, C., Zagani, R., Remy, S., Tesson, L., Mazal, D., Ubillos, L., Brion, R., Ashgar, K., et al. (2005) · The FASEB Journal · doi:10.1096/fj.05-3875com · Cited by 158
Van Ummersen, L., Binger, K., Volkman, J., Marnocha, R., Tutsch, K., Kolesar, J., Arzoomanian, R., Alberti, D., & Wilding, G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0406 · Cited by 158
INCREASED RISK OF BLADDER CANCER ASSOCIATED WITH A GLUTATHIONE PEROXIDASE 1 CODON 198 VARIANT
Ichimura, Y., Habuchi, T., Tsuchiya, N., Wang, L., Oyama, C., Sato, K., Nishiyama, H., Ogawa, O., & Kato, T. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000130942.40597.9d · Cited by 149
Couldwell, W. T., Weiss, M. H., DeGiorgio, C. M., Weiner, L. P., Hinton, D. R., Ehresmann, G. R., Conti, P. S., & Apuzzo, M. L. J. (1993) · Neurosurgery · doi:10.1227/00006123-199303000-00034 · Cited by 146
Kang, D., Lee, K.-M., Park, S. K., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0160 · Cited by 144
Nakamura, H., Masutani, H., Tagaya, Y., Yamauchi, A., Inamoto, T., Nanbu, Y., Fujii, S., Ozawa, K., & Yodoi, J. (1992) · Cancer · doi:10.1002/1097-0142(19920415)69:8<2091::aid-cncr2820690814>3.0.co;2-x · Cited by 141
Activation of hepatocyte protein kinase C by redox-cycling quinones
Kass, G. E. N., Duddy, S. K., & Orrenius, S. (1989) · Biochemical Journal · doi:10.1042/bj2600499 · Cited by 137
Cullen, J. J., Mitros, F. A., & Oberley, L. W. (2003) · Pancreas · doi:10.1097/00006676-200301000-00005 · Cited by 136
Yin, H., & Glass, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024080 · Cited by 135
Redox signaling: Potential arbitrator of autophagy and apoptosis in therapeutic response
Zhang, L., Wang, K., Lei, Y., Li, Q., Nice, E. C., & Huang, C. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.030 · Cited by 132
Molecular mechanisms of antiestrogen action in breast cancer
Jordan, V. C. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00689675 · Cited by 130
Discovery of a Small Molecule MDM2 Inhibitor (AMG 232) for Treating Cancer
Rew, Y., & Sun, D. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500627s · Cited by 125
Inhibition of protein kinase C mediated signal transduction by tamoxifen
Horgan, K. J., Cooke, E., Hallett, M. B., & Mansel, R. E. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90764-1 · Cited by 123
Protein Kinase C α but not PKCζ Suppresses Intestinal Tumor Formation in ApcMin/+ Mice
Oster, H., & Leitges, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0268 · Cited by 123
Richardson, P. G. G., Wolf, J., Jakubowiak, A. J., Zonder, J., Lonial, S., Irwin, D. H., Densmore, J. J., Krishnan, A. Y., Raje, N. S., Bar, M. H., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.9788 · Cited by 121
Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma
Wang, S., Davis, S., Cerhan, J. R., Hartge, P. A., Severson, R. K., Cozen, W., Lan, Q., Welch, R. A., Chanock, S. J., & Rothman, N. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl013 · Cited by 120
Tolcher, A. W., Reyno, L. M., Venner, P. M., Ernst, S., Moore, M. J., Geary, R. S., Chi, K., Hall, S. R. R., Walsh, W., Dorr, A., et al. (2002) · PubMed · Cited by 119
Montero, A. J., Diaz-Montero, C. M., Deutsch, Y. E., Hurley, J. E., Koniaris, L. G., Rumboldt, T., Yasir, S., Jorda, M., Garret-Mayer, E., Avisar, E., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1889-0 · Cited by 117
Arsova‐Sarafinovska, Z., Matevska-Geshkovska, N., Eken, A., Petrovski, D., Banev, S., Dzikova, S., Georgiev, V., Sikole, A., Erdem, O., Sayal, A., et al. (2008) · International Urology and Nephrology · doi:10.1007/s11255-008-9407-y · Cited by 116
Wei, Q., Jiang, H., Xiao, Z., Baker, A. R., Young, M. R., Veenstra, T. D., & Colburn, N. H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013012108 · Cited by 113
Gene Expression Profiling of Lymphoid Malignancies
Staudt, L. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103941 · Cited by 112
Zha, J., Chen, F., Dong, H., Shi, P., Yao, Y., Zhang, Y., Li, R., Wang, S., Li, P., Wang, W., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-163 · Cited by 111
Whitaker, H., Patel, D., Howat, W., Warren, A., Kay, J., Sangan, T., Marioni, J., Mitchell, J., Aldridge, S., Luxton, H. J., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.396 · Cited by 105
Fujii, S., Nanbu, Y., Nonogaki, H., Konishi, I., Mori, T., Masutani, H., & Yodoi, J. (1991) · Cancer · doi:10.1002/1097-0142(19911001)68:7<1583::aid-cncr2820680720>3.0.co;2-n · Cited by 100
Wang, F., Yang, J., Yu, K., Xu, M., Xu, Y., Chen, L., Lu, Y., Fang, H., Wang, X., Hu, Z., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-014-0274-0 · Cited by 99
Tsai, J., Wang, H., Liu, P., Chen, Y., Yang, M.-C., Chou, S., Cheng, Y.-J., Yin, W. H., Hwang, J.-J., & Chong, I. (2012) · Cellular Oncology · doi:10.1007/s13402-012-0105-5 · Cited by 98
Amin, A. R. M. R., Senga, T., Oo, M. L., Thant, A. A., & Hamaguchi, M. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00652.x · Cited by 95
Raaschou‐Nielsen, O., Sørensen, M., Hansen, R. D., Frederiksen, K., Tjønneland, A. M., Overvad, K., & Vogel, U. B. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.05.006 · Cited by 94
Baker, A. F., Dragovich, T., Tate, W. R., Ramanathan, R. K., Roe, D., Hsu, C.-H., Kirkpatrick, D. L., & Powis, G. (2006) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.09.001 · Cited by 90
Dvořáková, K., Payne, C. M., Tome, M. E., Briehl, M. M., McClure, T. D., & Dorr, R. T. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00380-4 · Cited by 89
Menadione Induces Both Necrosis and Apoptosis in Rat Pancreatic Acinar AR4-2J Cells
Sata, N., Klonowski-Stumpe, H., Han, B., Häussinger, D., & Niederau, C. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00064-6 · Cited by 88
You, A., Nam, C.-W., Wakabayashi, N., Yamamoto, M. P., Kensler, T. W., & Kwak, M.-K. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.12.034 · Cited by 88
Faderl, S. H., Rai, K., Gribben, J. G., Byrd, J. C., Flinn, I. W., O'Brien, S. M., Sheng, S., Esseltine, D.-L. W., & Keating, M. J. (2006) · Cancer · doi:10.1002/cncr.22097 · Cited by 85
Tibullo, D., Barbagallo, I. A., Giallongo, C., Cava, P. L., Parrinello, N. L., Vanella, L., Stagno, F., Palumbo, G. A., Volti, G. L., & Raimondo, F. D. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319150012 · Cited by 85
Tamoxifen for women at high risk of breast cancer
Narod, S. A., & Nazarali, S. A. (2014) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s43763 · Cited by 84
Identification of NCF2/p67phox as a novel p53 target gene
Italiano, D., Lena, A. M., Melino, G., & Candi, E. (2012) · Cell Cycle · doi:10.4161/cc.22853 · Cited by 83
Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma
Marengo, B., Ciucis, C. D., Verzola, D., Pistoia, V., Raffaghello, L., Patriarca, S., Balbis, E., Traverso, N., Cottalasso, D., Pronzato, M. A., et al. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.10.031 · Cited by 82
Self-citationUpregulation of PKC-δ contributes to antiestrogen resistance in mammary tumor cells
Nabha, S. M., Glaros, S., Hong, M., Lykkesfeldt, A. E., Schiff, R., Osborne, C. K., & Reddy, K. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208502 · Cited by 82
Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL
Liu, F., Agrawal, S. G., Gribben, J. G., Ye, H., Du, M., Newland, A. C., & Jia, L. (2007) · Blood · doi:10.1182/blood-2007-08-110445 · Cited by 81
Kahlos, K., Anttila, S., Asikainen, T. M., Kinnula, K., Raivio, K. O., Mattson, K. V., Linnainmaa, K., & Kinnula, V. L. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.4.2943 · Cited by 79
Grosjean-Raillard, J., Tailler, M., Adès, L., Perfettini, J., Fabre, C., Braun, T., de Botton, S., Fenaux, P., & Kroemer, G. (2008) · Oncogene · doi:10.1038/onc.2008.457 · Cited by 78
Vink, S. R., Schellens, J. H. M., Beijnen, J. H., SINDERMANN, H., Engel, J., Dubbelman, R., Moppi, G., Hillebrand, M. J. X., Bartelink, H. G. M. M., & Verheij, M. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.07.032 · Cited by 77
Lu, W., Fu, Z., Wang, H., Feng, J., Wei, J., & Guo, J. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1891-4 · Cited by 77
Rengan, R., Mick, R., Pryma, D. A., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182435aa6 · Cited by 75
Role of Cyclooxygenase 2 in Protein Kinase C βII-mediated Colon Carcinogenesis
Yu, W., Murray, N. R., Weems, C. R., Chen, L., Guo, H., Ethridge, R. T., Ceci, J. D., Evers, B. M., Thompson, E. A., & Fields, A. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211424200 · Cited by 73
PKC delta and NADPH oxidase in retinoic acid-induced neuroblastoma cell differentiation
Nitti, M., Furfaro, A. L., Cevasco, C., Traverso, N., Marinari, U. M., Pronzato, M. A., & Domenicotti, C. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.01.007 · Cited by 72
Self-citationChao, C., Lii, C., Hsu, Y., Lu, C., Liu, K., Li, C., & Chen, H. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt131 · Cited by 72
Strategies for Prolonged Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
Fidias, P. M., & Novello, S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7074 · Cited by 68
Forman, H. J., Torrès, M., & Fukuto, J. M. (2002) · PubMed · Cited by 67
Motexafin Gadolinium Disrupts Zinc Metabolism in Human Cancer Cell Lines
Magda, D. J., Lecane, P. S., Miller, R. A., Lepp, C., Miles, D., Mesfin, M., Biaglow, J. E., Ho, V. V., Chawannakul, D., Nagpal, S., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4099 · Cited by 66
Langzam, L., Koren, R., Gal, R., Kugel, V., Paz, A., Farkas, A., & Sampson, S. R. (2001) · American Journal of Clinical Pathology · doi:10.1309/1vkk-hwh7-yvjn-7uf7 · Cited by 66
Raza, A., Galili, N., Smith, S. E., Godwin, J. E., Lancet, J. E., Melchert, M., Jones, M., Keck, J., Meng, L., Brown, G. L., et al. (2009) · Blood · doi:10.1182/blood-2009-01-176032 · Cited by 65
Neill, G. W., Ghali, L. R., Green, J. L., Ikram, M. S., Philpott, M. P., & Quinn, A. (2003) · PubMed · Cited by 65
PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model
Yun, H., Park, K., Park, M. H., Kim, D. H., Jo, M. R., Kim, J. Y., Kim, E.-C., Yoon, D. Y., Han, S., & Hong, J. T. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.12.022 · Cited by 64
Suppression of Peroxiredoxin 4 in Glioblastoma Cells Increases Apoptosis and Reduces Tumor Growth
Kim, T. H., Song, J., Llaguno, S. R. A., Murnan, E., Liyanarachchi, S., Palanichamy, K., Yi, J.-Y., Viapiano, M. S., Nakano, I., Yoon, S. O., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042818 · Cited by 64
Tibullo, D., Barbagallo, I. A., Giallongo, C., Vanella, L., Conticello, C., Romano, A., Saccone, S., Godos, J., Raimondo, F. D., & Volti, G. L. (2016) · Oncotarget · doi:10.18632/oncotarget.7563 · Cited by 63
Kona, F. R., Buac, D., & Burger, A. M. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794519798 · Cited by 59
Millward, M. J., House, C. M., Bowtell, D. D. L., Webster, L. K., Olver, I., Gore, M. E., Copeman, M. C., Lynch, K., Yap, A., Wang, Y., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603331 · Cited by 54
HO-1 up-regulation: A key point in high-risk neuroblastoma resistance to bortezomib
Furfaro, A. L., Piras, S., Passalacqua, M., Domenicotti, C., Parodi, A., Fenoglio, D., Pronzato, M. A., Marinari, U. M., Moretta, L., Traverso, N., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.008 · Cited by 54
Self-citationp38 MAP kinase signaling is necessary for rat chondrosarcoma cell proliferation
Halawani, D., Mondeh, R., Stanton, L., & Beier, F. (2004) · Oncogene · doi:10.1038/sj.onc.1207422 · Cited by 53
Mitomycin C and menadione for the treatment of lung cancer: a phase II trial
Tetef, M. L., Margolin, K. A., Ahn, C. W., et al. (1995) · Investigational New Drugs · doi:10.1007/bf00872865 · Cited by 52
MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma
Liu, G., Zhou, W., Wang, L. I., Park, S., MILLER, D. P., Xu, L. L., Wain, J. C., Lynch, T. J., Su, L., & Christiani, D. C. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.027 · Cited by 52
Shiota, M., Yokomizo, A., Kashiwagi, E., Takeuchi, A., Fujimoto, N., Uchiumi, T., & Naito, S. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.001 · Cited by 49
Tang, P., Roldán, G. B., Brasher, P. M. A., Fulton, D. S., Roa, W., Murtha, A. D., Cairncross, J. G., & Forsyth, P. A. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-9104-y · Cited by 48
Troiani, T., Vecchione, L., Martinelli, E., Capasso, A., Costantino, S., Ciuffreda, L. P., Morgillo, F., Vitagliano, D., D’Aiuto, E., Palma, R. D., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.129 · Cited by 46
Hoover, A. C., Milhem, M. M., Anderson, C. M., Sun, W., Smith, B. J., Hoffman, H. T., & Buatti, J. M. (2014) · Head & Neck · doi:10.1002/hed.23664 · Cited by 45
Matulonis, U. A., Horowitz, N. S., Campos, S. M., Lee, H., Lee, J., Krasner, C. N., Berlin, S. T., Roche, M. R., Duska, L., Pereira, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0282 · Cited by 43
Xu, J., Tian, W., Ma, X., Guo, J., Shi, Q., Jin, Y., Xi, J., & Xu, Z. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9213-5 · Cited by 42
Furfaro, A. L., Macay, J. R. Z., Marengo, B., Nitti, M., Parodi, A., Fenoglio, D., Marinari, U. M., Pronzato, M. A., Domenicotti, C., & Traverso, N. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.007 · Cited by 42
Self-citationNOV-002, a mimetic of glutathione disulfide
Townsend, D. M., Pazoles, C. J., & Tew, K. D. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.7.1075 · Cited by 41
A Phase II Trial of ISIS 3521 in Patients with Metastatic Colorectal Cancer
Marshall, J. L., Eisenberg, S. G., Johnson, M. D., Hanfelt, J., Dorr, F. A., El‐Ashry, D., Oberst, M. D., Fuxman, Y., Holmlund, J., & Malik, S. M. (2004) · Clinical Colorectal Cancer · doi:10.3816/ccc.2004.n.026 · Cited by 40
Turunen, N., Karihtala, P., Mäntyniemi, A., Sormunen, R. T., Holmgren, A., Kinnula, V. L., & Soini, Y. (2004) · Apmis · doi:10.1111/j.1600-0463.2004.apm1120207.x · Cited by 38
Marengo, B., Ciucis, C. G. D., Ricciarelli, R., Furfaro, A. L., Colla, R., Canepa, E., Traverso, N., Marinari, U. M., Pronzato, M. A., & Domenicotti, C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.118 · Cited by 38
Self-citationNew Insights into Redox-Modulated Cell Signaling
Leonarduzzi, G., Sottero, B., Testa, G., Biasi, F., & Poli, G. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798764906 · Cited by 38
Barr, P. M., Miller, T. P., Friedberg, J. W., Peterson, D. R., Baran, A. M., Herr, M. M., Spier, C. M., Cui, H., Roe, D. J., Persky, D. O., et al. (2014) · Blood · doi:10.1182/blood-2014-04-570044 · Cited by 37
Nam, S. Y., & Sabapathy, K. (2011) · Oncogene · doi:10.1038/onc.2011.150 · Cited by 37
Moulder, S. L., Dhillon, N., Ng, C. S., Hong, D. S., Wheler, J. J., Naing, A., Tse, S., LaPaglia, A., Dorr, R. T., Hersh, E. M., et al. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9273-1 · Cited by 35
Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cells.
Dvořáková, K., Payne, C. M., Tome, M. E., Briehl, M. M., Vasquez, M., Waltmire, C. N., Coon, A., & Dorr, R. T. (2002) · PubMed · Cited by 33
Reactive oxygen species: biological stimuli of neuroblastoma cell response.
Marengo, B., Raffaghello, L., Pistoia, V., Cottalasso, D., Pronzato, M., Marinari, U., & Domenicotti, C. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.01.046 · Cited by 32
Self-citation
Cited by
ROS and the DNA damage response in cancer
Srinivas, U. S., Tan, B. W. Q., Vellayappan, B. A., & Jeyasekharan, A. D. (2019) · Redox Biology · doi:10.1016/j.redox.2018.101084 · Cited by 2,144
“Secondly, ROS has a dose dependent effect on activity of proteins leading to differential downstream outcomes [140], which are”
BackgroundNRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672
ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway
Zhao, Y., Hu, X., Liu, Y., Dong, S., Wen, Z., He, W., Zhang, S., Huang, Q., & Shi, M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0648-1 · Cited by 735
Emerging roles of lipid metabolism in cancer metastasis
Luo, X., Cheng, C., Tan, Z., Li, N., Tang, M., Yang, L., & Cao, Y. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0646-3 · Cited by 677
Metabolic programming and immune suppression in the tumor microenvironment
Arner, E. N., & Rathmell, J. C. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.01.009 · Cited by 668
Metadata
- Authors
- Marengo, B., Nitti, M., Furfaro, A. L., Colla, R., Ciucis, C. D., Marinari, U. M., Pronzato, M. A., Traverso, N., & Domenicotti, C.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2016-01
- Volume
- 2016
- Issue
- 1
- Pages
- 6235641-6235641
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W2468344619
- Cited by
- 319
- References
- 218
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.